1.Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53. http://doi: 10.1002/ijc.31937.
2.Guideline based on the effective evaluation of cervical cancer. Japan Council for Quality Health Care. 2009. Accessed 17 June 2019. https://minds.jcqhc.or.jp/n/med/4/med0071/G0000193/0005 (in Japanese)
3.Japanese Ministry of Health, Labour and Welfare.Incidence of Cancer in Japan. MHLW. 2016. Accessed 17 June 2019. https://www.mhlw.go.jp/content/10900000/000468976.pdf (in Japanese)
4.National Cancer Center Japan. CANCER STATISTICS IN JAPAN ’16. Accessed 17 June 2019. https://ganjoho.jp/reg_stat/statistics/index.html
5.Organisation for Economic Co-operation and Development (OECD). OECD Health Statistics 2018. Accessed 29 Sep 2018. https://stats.oecd.org/index.aspx?DataSetCode = HEALTH_STAT
6.Centers for Disease Control and Prevention, Epidemiology and Prevention of Vaccine-Preventable Diseases. Chapter 11: Human Papillomavirus. Accessed 16 June 2019. https://www.cdc.gov/vaccines/pubs/pinkbook/hpv.html
7.Suzuki S, and Hosono A. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: results of the Nagoya study. Papillomavirus Res. 2018;5:93–103. http://doi: 10.1016/j.pvr.2018.02.002.
8.Miyagi E, Motoki Y, Asai-Sato M, Taguri M, Morita S, Hirahara F, et al. Web-based recruiting for a survey on knowledge and awareness of cervical cancer prevention among young women living in Kanagawa prefecture, Japan. Int. J Gynecol Cancer. 2014;24(7):1347–55. http://doi: 10.1097/IGC.0000000000000220.
9.Japanese Ministry of Health, Labour and Welfare.Number of regular vaccination practitioners. MHLW. 2018. Accessed 17 June 2019. https://www.mhlw.go.jp/topics/bcg/other/5.html (in Japanese)
10.Hamashima C, Aoki D, Miyagi E, Saito E, Nakayama T, Sagawa M, et al. The Japanese Guideline for Cervical Cancer Screening. Jpn J Clin Oncol. 2010;40(6):485–502. http://doi: 10.1093/jjco/hyq036.
11.Matsuo I, Nishizawa Y, Matsuo K, Kagiya A. Cervical cancer screening behavior and factors associated with screening behavior. Hirosaki med. J. 2014;64 (2):103–118.
12. Sano H, Goto R, Hamashima C. Does lack of resources impair access to breast and cervical cancer screening in Japan? PLoS One. 2017;13;12(7):e0180819. http://doi: 10.1371/journal.pone.
0180819.
13.Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Jaspars LH, Voorhorst FJ, et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreening women. J Clin Pathol. 2002;55(6):435–9.
14.Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, et al. Accuracy of human pap illomavirus testing on self-collected versus clinician-collected samples: A meta-analysis. Lancet Oncol. 2014;15(2):172–83. http://doi: 10.1016/S1470–2045(13)70570–9.
15.Ketelaars PJW, Bosgraaf RP, Siebers AG, Massuger LFAG, van der Linden JC, Wauters CAP, et al. High-risk human papillomavirus detection in self-sampling compared to physician-
taken smear in a responder population of the Dutch cervical screening: Results of the VERA study. Prev Med. 2017;101:96–101. http://doi: 10.1016/j.ypmed.2017.05.021.
16.Polman NJ, Ebisch RMF, Heideman DAM, Melchers WJG, Bekkers RLM, Molijn AC, et al. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial. Lancet Oncol. 2019;20(2):229–238. http://doi: 10.1016/S1470–2045(18) 30763–0.
17.Oshima S, and Maezawa M. Perception of cervical screening among Japanese university students who have never had a Pap smear: a qualitative study. Asian Pac J Cancer Prev. 2013;14(7):4313–8. http://dx.doi.org/10.7314/APJCP.2013.14.7.4313
18.Sultana F, Mullins R, English DR, Simpson JA, Drennan KT, Heley S, et al. Women’s experience with home-based self-sampling for human papillomavirus testing. BMC Cancer. 2015;15:849. http://doi: 10.1186/s12885–015–1804-x
19.Winer RL, Gonzales AA, Noonan CJ, Cherne SL, Buchwald DS; Collaborative to Improve Native Cancer Outcomes (CINCO). Assessing Acceptability of Self-Sampling Kits, Prevalence, and Risk Factors for Human Papillomavirus Infection in American Indian Women. J Community Health. 2016;41(5):1049–61. http://doi: 10.1007/s10900–016–0189–3.
20.Hanley SJ, Fujita H, Yokoyama S, Kunisawa S, Tamakoshi A, Dong P, et al. HPV self-sampling in Japanese women: A feasibility study in population with limited experience of tampon use. J Med Screen. 2016;23(3):164–70. http://doi 10.1177/096914135625702.
21.Thay S, Goldstein A, Goldstein LS, Govind V, Lim K, Seang C. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy. BMJ Open. 2019;9(2):e026887. http://doi:10.1136/bmjopen–2018–026887
22.Zehbe I, Jackson R, Wood B, Weaver B, Escott N, Severini A, et al. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology. BMJ Open. 2016;6(10):
e011754. http://doi: 10.1136/bmjopen- 2016- 011754.
23. Hanley S, Fujita H, Tamakoshi A, et al.HPV self sampling: A novel method to increase cervical screening uptake.Japanese association for cancer detection and diagnosis. 2014;28(1):22. unpublished.
24.Bosgraaf RP, Ketelaars PJ, Verhoef VM, Massuger LF, Meijer CJ, Melchers WJ, et al. Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women. Prev Med. 2014;64:108–13. http://doi: 10.1016/j.ypmed.2014.04.011.
25.Madzima TR, Vahabi M, Lofters A. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women Focused literature review. Can Fam Physician. 2017;63(8):597–601.
26.Tranberg M, Bech BH, Blaakær J, Jensen JS, Svanholm H, Andersen B. HPV self-sampling in cervical cancer screening: the effect of different invitation strategies in various socioeconomic groups - a randomized controlled trial. Clin Epidemiol. 2018;10:1027–1036. http://doi: 10.2147/CLEP.S164826.
27.Nelson EJ, Maynard BR, Loux T, Fatla J, Gordon R, Arnold LD. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis. Sex Transm Infect. 2017;93(1):56–61. http://doi: 10.1136/sextrans–2016–052609.
28. Williams D, Davies M, Fiander A, Farewell D, Hillier S, Brain K. Women’s perspectives on human papillomavirus self-sampling in the context of the UK cervical screening programme. Health Expect. 2017;20(5):1031–40. http://doi: 10.1111/hex.12544.
29.Crofts V, Flahault E, Tebeu PM, Untiet S, Fosso GK, Boulvain M, et al. Education efforts may contribute to wider acceptance of human papillomavirus self-sampling. Int J Womens Health. 2015;7:149–54. http://doi: 10.2147/IJWH.S56307.
30.Penaranda E, Molokwu J, Flores S, Byrd T, Brown L, Shokar N. Women’s attitudes toward cervicovaginal self-sampling for high-risk HPV infection on the US-Mexico border. J Low Genit Tract Dis. 2015;19(4):323–8. http://doi: 10.1097/LGT.0000000000000134.
31.National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport. Screening for CERVICAL CANCER Invitation RIVM, 2018. Accessed 5 Dec 2018. https://www.rivm.nl/sites/default/files/201811/96987_009285_Uitnodigingsfolder_BVO_BMHK_ENG_TG.pdf.
32.Australian Government Department of Health. National cervical screening program. Australian Government, 2018. Accessed 17 June 2019. https://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/cervical-screening–1
33.Duke P, Godwin M, Ratnam S, Dawson L, Fontaine D, Lear A, et al. Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland. BMC Women’s Health. 2015;15:47. http://doi: 10.1186/s12905–015–0206–1.
34.Yeh PT, Kennedy CE, de Vuyst H, Narasimhan M. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Glob Health. 2019;4(3):e001351. http://doi: 10.1136/bmjgh–2018–001351.